LARCAVIXIMAB
UNII 181UPT812X

Substance Identification & Data

This profile provides standardized clinical and technical data for Larcaviximab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 181UPT812X.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1792982-56-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

181UPT812X

CAS Registry Number

1792982-56-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LARCAVIXIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166475

National Cancer Institute reference terminology for clinical and research data.

INN ID

10537

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DE-21

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Larcaviximab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LARCAVIXIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(EBOLAVIRUS GLYCOPROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL C4G7 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL C4G7 .KAPPA.-CHAIN, DIMER

LARCAVIXIMAB [INN]

LARCAVIXIMAB [USAN]

LARCAVIXIMAB [WHO-DD]